Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?

Johnson, William

Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all? [electronic resource] - Haematologica 05 2019 - 864-867 p. digital

Publication Type: Editorial; Comment

1592-8721

10.3324/haematol.2018.214536 doi


Adult
Antibodies, Monoclonal, Humanized
Humans
Leukemia-Lymphoma, Adult T-Cell
Lymphoma
Recurrence